Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Condition: Mesothelioma Interventions: Drug: Durvalumab / tremelimumab; Drug: Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab Sponsors: Baylor College of Medicine; Duke Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma
Condition: Pleural Mesothelioma Intervention: Drug: Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin Sponsor: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials